nivolumab,ipilimumab
bms
['gu ', 'nivolumab', 'hcrn,gu16,260', 'hcrn,gu,16,260', 'rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo']
dr. david braun shares insight into his study of nivolumab monotherapy for renal cell carcinoma #rcc during poster session c at gu cancers symposium. #gu23 saturday, feb. 18 10:00am est 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.